Physician profile
Cindy A Mora
NPI 1891385464
$2,437.57
in general payments reported to CMS, 2019-2025
22 companies · $576 in 2025
The $576 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.80 · 2022: $504 · 2023: $646 · 2024: $624 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,805.59 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $469.44 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $326.69 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $297.18 | 2022-2025 | |
| Abbvie INC. | $219.43 | 2021-2023 | |
| Exact Sciences Corporation | $141.32 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $137.83 | 2022-2024 | |
| Coopersurgical, INC. | $119.07 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $108.40 | 2022-2023 | |
| Astellas Pharma Global Development | $104.70 | 2025 | Veozah |
| Organon LLC | $93.57 | 2022-2025 | Nexplanon |
| Myovant Sciences INC. | $86.97 | 2022 | |
| Exeltis, USA INC. | $66.50 | 2023-2025 | Slynd |
| Millicent US INC | $61.54 | 2024 | Intrarosa, Femring |
| Biogen, INC. | $51.47 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $28.31 | 2023 | Accrufer |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mycovia Pharmaceuticals, INC. | $24.71 | 2023 | Vivjoa |
| Hologic Sales and Service, LLC | $23.57 | 2021 | |
| Acella Pharmaceuticals, LLC | $20.60 | 2023 | NP Thyroid 60 |
| Merck Sharp & Dohme LLC | $15.36 | 2024 | Gardasil, Gardasil 9 |
| Therapeuticsmd, INC. | $14.82 | 2022 | |
| Avion Pharmaceuticals | $14.56 | 2022 | |
| Agile Therapeutics, INC. | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Mora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.